
Scegli la tua etichetta
mostrata direttamente sul flaconcinoSemaglutide Oral
GLP-1 Oral
- Spedito dalla Germania
Ordine
- DHL con tracciamento
- Imballaggio discreto
4.6 su 5 su Trustpilot73 recensioni
Cercato anche come: Semaglutid Oral · Semaglutid Tabletten
In sintesi
Semaglutide Oral in cifre
I dati chiave dalla nostra enciclopedia.
Voce completa dell'enciclopedia- Class
- GLP-1 agonistoral
- Half-life
- longdosed daily
- Use
- Oral, fastedin mg/day
- Sizes
- 2 sizes3mg/25tabs, 7mg/25tabs
What studies show
The source in the lexiconPIONEER 1: oral semaglutide as monotherapy in type 2 diabetes (randomized) (opens in a new tab)
Aroda et al., Diabetes Care, 2019
Recensioni
Cosa dicono i clienti
Solo ordini reali che includevano Semaglutide Oral.
Tutte le recensioniNon esiste ancora un'analisi di laboratorio per Semaglutide Oral. Vota a favoreFallo testare tu, noi paghiamo la metàTutte le analisi di laboratorio
Conoscenze
Tutto su Semaglutide Oral
Informazioni dettagliate in arrivo.
Is this the same compound as the injection?
Yes. Semaglutide is a GLP-1 analogue with 94 percent sequence match to the body's own GLP-1. The tablet also contains SNAC, which enables absorption in the stomach. Because only a small part arrives, the milligram figures are higher than with the injection.
Is oral semaglutide approved?
Yes. ChEMBL lists semaglutide as an approved compound with first approval in 2017, the tablet has its own US label. On ClinicalTrials.gov a search for oral semaglutide gives 204 trials (as of 26 October 2026). Everything here is the state of research, not a recommendation.
Why fasted and with little water?
According to the label only about 0.4 to 1 percent reaches the blood. In studies in healthy people absorption was higher with little water than with a large glass. The longer nothing was eaten after the tablet, the more arrived. Hence the strict intake rule in the entry.
What did PIONEER 1 show?
703 people with type 2 diabetes using only diet and exercise received one of three doses or placebo. After 26 weeks HbA1c was 0.6 to 1.1 percentage points lower than with placebo. Weight fell clearly only on the highest study dose, by 2.3 kg more than on placebo.
What about the heart?
PIONEER 6 with 3,183 people showed that cardiovascular risk does not rise (3.8 versus 4.8 percent). SOUL with 9,650 people with vascular or kidney disease found 12.0 instead of 13.8 percent major events over about four years, so 14 percent fewer.
Which side effects are typical?
Mainly gastrointestinal complaints. According to the label 20 percent had nausea on the highest study dose, 6 percent on placebo. In addition there were abdominal pain, diarrhoea, decreased appetite, vomiting and constipation. The label also names rare risks such as pancreatitis and gallbladder problems.
Correlati
Prodotti correlati
Semaglutide Oral